Indoco Remedies Limited

NSEI:INDOCO Stok Raporu

Piyasa değeri: ₹29.5b

Indoco Remedies Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Indoco Remedies yıllık ortalama 13.4% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 13.3% annual. Gelirler growing yılda ortalama 11.6% oranında artmaktadır. Indoco Remedies'in özkaynak karlılığı 2.7% ve net marjı 1.8%'dir.

Anahtar bilgiler

13.4%

Kazanç büyüme oranı

13.1%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi17.5%
Gelir büyüme oranı11.6%
Özkaynak getirisi2.7%
Net Marj1.8%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

May 24
Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

Recent updates

Indoco Remedies Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Oct 27
Indoco Remedies Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

May 24
Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts

Jan 26
Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts

Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?

Jan 26
Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now

Sep 16
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now

Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly

May 21
Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly

Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Aug 31
Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Jul 04
Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Jul 02
Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly

Jun 10
Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly

Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Mar 25
Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price

Mar 09
Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price

What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?

Feb 22
What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?

Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?

Feb 07
Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?

Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 17
Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Is Indoco Remedies (NSE:INDOCO) A Risky Investment?

Dec 27
Is Indoco Remedies (NSE:INDOCO) A Risky Investment?

Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)

Dec 06
Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)

What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?

Nov 14
What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?

Gelir ve Gider Dağılımı

Indoco Remedies nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NSEI:INDOCO Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2417,7323214,685875
30 Jun 2418,2237673,677980
31 Mar 2418,1739854,621972
31 Dec 2317,9581,0164,219979
30 Sep 2317,3561,1344,141936
30 Jun 2316,8691,2813,307866
31 Mar 2316,6861,4233,941810
31 Dec 2216,4961,5693,718766
30 Sep 2216,0841,6173,616738
30 Jun 2215,6221,5373,014764
31 Mar 2215,4081,5483,435746
31 Dec 2114,3681,3933,407714
30 Sep 2114,1101,3173,423716
30 Jun 2113,5241,1572,832660
31 Mar 2112,4159303,341597
31 Dec 2012,0847343,372573
30 Sep 2011,6545713,326529
30 Jun 2011,2983932,614488
31 Mar 2011,0662413,167497
31 Dec 1910,9093022,916488
30 Sep 1910,6402642,825483
30 Jun 1910,0711112,767494
31 Mar 199,684-292,721515
31 Mar 1810,4244122,637535
31 Mar 1710,9687712,605517
31 Mar 1610,0818192,141432
31 Mar 158,5708281,664217
31 Mar 147,3365802,616208

Kaliteli Kazançlar: INDOCO yüksek düzeyde nakit dışı kazança sahiptir.

Büyüyen Kar Marjı: INDOCO 'nin mevcut net kar marjları (1.8%) geçen yılın (6.5%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: INDOCO şirketinin kazancı son 5 yılda yılda 13.4% oranında arttı.

Büyüme Hızlandırma: INDOCO 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: INDOCO geçtiğimiz yıl negatif kazanç büyümesine ( -71.7% ) sahipti ve bu da onu Pharmaceuticals sektör ortalamasıyla ( 20.5% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: INDOCO 'nin Özsermaye Getirisi ( 2.7% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin